PAR 3.41% 22.8¢ paradigm biopharmaceuticals limited..

1 USD BILL REVENUE would command a higher P/E ratio than...

  1. 300 Posts.
    lightbulb Created with Sketch. 84
    1 USD BILL REVENUE would command a higher P/E ratio than 20…….for many reasons. SubQ, stable compound, safety record, indications OA, pain off label, DMOAD, retreatment,

    Team (Paul, Donna, SW, KOL):

    Bring on the DMOAD label clarity
    Bring on the phase 3 stage 2 dose of 2mg/kg twice weekly.
    Bring on a non dilutive funding solution.

    Let’s stop sitting around scratching our heads about which way this is going. Lay the path…. let’s walk it, run it and accelerate it.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.8¢
Change
0.008(3.41%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.5¢ 23.5¢ 22.5¢ $15.77K 69.15K

Buyers (Bids)

No. Vol. Price($)
6 151795 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 132937 2
View Market Depth
Last trade - 12.46pm 15/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.